Evidence for Contrast-Enhanced Ultrasound in Fenestrated EVAR Surveillance by Sun, Zhonghua
1 
 






Discipline of Medical Imaging, Department of Imaging and Applied Physics, Curtin 




Professor Zhonghua Sun, Discipline of Medical Imaging, Department of Imaging and 
Applied Physics, Curtin University, GPO Box, U1987, Perth, Western Australia 6845, 
Australia 
Tel: +61-8-9266 7509 




Endovascular aneurysm repair (EVAR) has been reported as an effective alternative to open 
surgical repair.
1,2
  Since its first introduction into clinical practice in the early 1990s, 
endovascular stent-grafting has progressed rapidly, following an improved understanding of 
the strengths and limitations of various devices and treated patient populations.
3-6
 
Endovascular technology has evolved to produce fenestrated stent-grafts which are designed 
to deal with patients with short-necked and juxtarenal aneurysms.
7-18
 Fenestrated stent-grafts 
have concerns similar to those that apply to conventional endovascular repair, i.e., structural 
durability, endoleak, renal dysfunction, and migration.  Moreover, there is the potential loss 
of the target vessel resulting from the fenestrated technique.  Two published systematic 
reviews confirm the potential lower perioperative mortality of the fenestrated technique in 
comparison with open repair, based on short to midterm data.
19, 20
 Fenestrated stent-grafts 
have become commercially available and provide an alternative to open surgery, especially in 
patients who are unfit for open repair or standard endovascular repair. 
Although fenestrated repair of abdominal aortic aneurysms (AAA) has been shown to reduce 
perioperative mortality compared to open repair, it is associated with a higher rate of 
subsequent re-intervention.
19
 Thus, postoperative surveillance is considered mandatory to 
identify graft-related complications such as visceral vessel stenosis and to direct re-
intervention and avoid later morbidity and mortality.
21, 22
 Imaging techniques play an 
important role in the detection of any abnormalities associated with fenestrated endovascular 
repair. Helical computed tomographic angiography (CTA) is the routine technique used to 




The diagnostic value of CTA in EVAR has been enhanced with development of multislice 
CT technology and use of a series of 2-dimensional (2D) or 3D reconstructed visualizations 
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which are generated to improve the understanding of stent-grafts in relation to the aortic 
branches.
23-29 
CTA is currently the gold standard for EVAR surveillance, however, it is 
associated with radiation exposure.  This raises increasing concerns about the cumulative 
radiation dose of CTA, since patients treated with EVAR including fenestrated repair 
undergo regular surveillance imaging (serial CT scans) to monitor the integrity of the 
endovascular repair and to enable secondary intervention to prevent rupture should CT 
imaging reveal a problem.  It has been reported that the cumulative dose from a series of CT 
scans following EVAR could be as high as 205 mSv over five years. 
30 
This equates to a 
lifetime attributable risk of cancer of 0.60% (1 in 170).  In addition, CTA contributes to the 
decline in renal function after EVAR due to contrast-induced nephropathy.
31
 Therefore, 
duplex ultrasound, an alternative to CTA in the follow-up of EVAR, has been investigated as 
the potential method of imaging modality. 
In the current issue of the JEVT, Perini et al 
32
 evaluated the accuracy of contrast-enhanced 
ultrasound (CEUS) as an effective alternative to CTA in the endoleak detection, aneurysm 
sac diameter measurement and target vessel patency during follow-up after fenestrated 
EVAR.  The authors studied 62 patients (mean age 72 years) who underwent fenestrated 
EVAR with a maximum of 3 fenestrations.  Both CEUS and CTA examinations were 
performed in all patients for comparative analysis.  Maximum aneurysm sac diameters were 
measured with both imaging modalities.  Detection of endoleaks was evaluated and 
differences in endoleak detection were assessed between the two modalities.  Target vessel 
patency following fenestrated EVAR was analyzed, and the agreement between two 
modalities was compared.  The authors demonstrated the good to excellent agreement 
between the two modalities in the follow-up performance based on the first postoperative 
images.  The mean difference in aneurysm sac diameter was –1.13±3.19 mm (95% CI –0.34 
to –1.92), with CTA measurements tending to be slightly larger.  Both CEUS and CTA 
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showed the same diagnostic accuracy with excellent agreement in the endoleak detection.  A 
complete agreement was reached between CEUS and CTA in the assessment of fenestrated 
vessels, with 144 (98.6%) vessel being patent, 1 having significant stenosis and another being 
thrombosed.  The study by Perini et al therefore concluded that CEUS is as accurate as CTA 
in monitoring endoleaks, aneurysm sac diameters, and target vessel patency in patients 
treated with fenestrated stent grafts.  CEUS is not recommended as the sole imaging modality 
for fenestrated EVAR surveillance, however, it could be used as an effective alternative to 
CTA due to its advantage of reducing lifetime exposure to ionizing radiation associated with 
the CTA scans. 
There are three observations from Perini’s study that bear discussions. First, the authors have 
validated CEUS in this study as an accurate modality for early follow-up of fenestrated 
EVAR.  Color duplex ultrasound scanning has been considered a potentially attractive 
alternative to CTA in the follow-up of patients after standard EVAR, as it is less expensive 
and does not involve ionizing radiation or potentially nephrotoxic contrast. 
33-36
 Several 
studies have reported excellent results with color duplex ultrasound compared to CTA, while 
others have concluded that CTA is still the technique for surveillance after EVAR.
37-40
 
Several authors have pointed out the usefulness of CEUS because it seems to allow better 
identification and characterization of endoleaks.
41-45
 In a study using CEUS, Napoli et al.
43
 
were able to differentiate a low-flow endoleak from endotension, which had been diagnosed 
on the basis of triple-phase contrast-enhanced CTA.  Similarly, Henao et al 
44
 confirmed the 
efficacy of CEUS to detect endoleaks compared to CTA, as their results demonstrated that 
CEUS detected all of the nine endoleaks, while CTA failed to recognize three type II 
endoleaks observed by CEUS.  CEUS may be used as a primary modality for the detection of 
endoleaks and characterization of the dynamic flow of endoleaks. Perini et al 
45 
in their recent 
study consisting of 395 patients who underwent both standard and fenestrated EVAR showed 
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the same efficacy by CEUS and CTA in post-EVAR follow-up. According to authors’ 
experience, CEUS has been recommended to replace the 6-month and 24-month CTA 
examinations in the standard EVAR surveillance. 
The second comment is related to some of the CEUS limitations which prevent it from being 
used as the sole imaging modality for fenestrated EVAR surveillance.  In addition to the well 
documented operator dependency of ultrasound examinations and patient factors (e.g., large 
body mass index, bowel gas), the authors noted that CEUS has limitations in the reliable 
detection of other complications such as stent fracture, limb kinking, stent graft migration or 
component separation.  In contrast, CTA provides superior information related to stent graft 
structure and integrity, and its diagnostic applications are augmented by 3D reconstructions 
which have been reported to provide valuable information for the assessment of stent graft 
migration, as well as its relationship with aortic branches.
23-29,46 
Despite the advantages of 
CTA in the identification of stent graft details, the deleterious effect on renal function, 
radiation exposure, and significant cost of this surveillance procedure are considered 
problematic.  As the authors recommended, 4-view abdominal radiographs should always be 
performed at the same time as ultrasound, 
47
 and their findings should be interpreted together.  
This significantly reduces the radiation dose as plain radiography produces radiation dose of 
less than 1 mSv, thus the radiation-induced risk of malignancy is negligible. 
The third comment is related to the clinical applicability of these findings to patients treated 
with fenestrated stent-grafts.  The authors highlighted the potential value of using CEUS as 
an alternative to CTA in the follow-up of fenestrated stent-grafts, however, their data was 
based on a single center experience and was restricted to the observation of the first 
postoperative investigation.  Furthermore, the limited number of patients and the number of 
abnormalities in their first follow-up series represents another limitation of the study.  The 
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authors indicated that further studies are necessary to better define the role of CEUS in 
surveillance of fenestrated EVAR.  Many clinical centers initially undertook surveillance 
protocols from those outlines in the randomised controlled trials or early registries,
48
 which 
used contrast-enhanced CT as the gold standard of surveillance.  However, excessive 
dependence on CT is expensive and exposes the patients to nephrotoxic intravenous contrast 
and ionizing radiation.
49,50
 Increasing the proportional use of non-nephrotoxic imaging 
modalities after EVAR has been advocated as an alternative approach to reduce surveillance-
related morbidity.
51
 Sternbergh et al 
52
 recommended a revised EVAR surveillance regimen 
according to their multicenter data from the US Zenith endovascular AAA trials.  On the 
basis of these data and 5-year follow-up outcomes, they proposed a modified surveillance 
protocol to alter the intensity and frequency of postoperative imaging follow-up.  In patients 
without early endoleaks, the 6-month surveillance is eliminated, and the yearly aortic 
ultrasound examination is recommended for long-term surveillance of more than 1 year.  
There is increasing evidence of a trend from using conventional CT follow-up to ultrasound 
monitoring,
52, 53 
so there is a need for a contemporary evaluation of surveillance after EVAR.  
A recent survey which was administered to 41 clinical centers experienced in EVAR in the 
UK has shown there is significant heterogeneity in national practice for postoperative 
surveillance after EVAR.
54
 Intensive use of CT was observed in some centers and this may 
lead to cumulative renal injury due to repeated administration of contrast agents and radiation 
exposure.  The heterogeneity seen in this survey reflects the ongoing uncertainty about the 
surveillance protocol following EVAR.  More evidence is needed to establish a consensus 
towards an optimal surveillance protocol that is clinically and economically effective. 
In summary, Perini and colleagues have successfully shown the accuracy of CEUS in the 
surveillance of fenestrated stent-grafts.  However, since the current study is based on a small 
number of patients and the first postoperative imaging session only, large-scale multicenter 
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studies are needed before generalizing conclusions regarding the use of CEUS in routine 
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